XML 45 R15.htm IDEA: XBRL DOCUMENT v3.25.3
Description of Business and Summary of Significant Accounting Policies (Tables)
 9 Months Ended
Sep. 30, 2025
Description of Business and Summary of Significant Accounting Policies [Abstract]  
Schedule of Cash, Cash Equivalents and Restricted Cash

The following is a summary of cash, cash equivalents and restricted cash at September 30, 2025 and December 31, 2024:

 

(in thousands)  September 30,
2025		   December 31,
2024		 
Cash and cash equivalents  $53,391   $72,904 
Restricted cash – long-term   332    324 
Cash, cash equivalents and restricted cash  $53,723   $73,228 
Schedule of Diluted Net Loss Per Share For the three and nine months ended September 30, 2025 and 2024, the Company’s potentially dilutive shares, which include outstanding common stock options, restricted stock units, vested unissued shares of common stock and warrants, have not been included in the computation of diluted net loss per share as the result would have been anti-dilutive.
(in thousands)  September 30,
2025		   September 30,
2024		 
Stock Options   162    5,216 
Restricted Stock Units   
-
    300 
Vested unissued shares of common stock   179    
-
 
Warrants   7    9 
Total   348    5,525